Latest filing published 14 Nov 2023 for HLS Therapeutics Inc., €58k.
Polar Asset Management Partners Inc. discloses dealings in HLS Therapeutics Inc. to SEDI. We count 4 filings; the first trade dates from 3 November 2023 and the latest from 10 November 2023.
Every open-market trade on record is a purchase: 3 purchases worth €94k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Half of the purchases are above €30k and half below. No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The latest filing, published on 14 November 2023, reports an open-market purchase of €58k in HLS Therapeutics Inc. Filings reach the SEDI feed a median of 5 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations